Tag
#Private Equity
13 articles
The LOI Is Not the Deal: The Chronological Anatomy of a 90-Day Enterprise Value Extraction
85% of dental practice sellers lose enterprise value after the buyer's Quality of Earnings audit. Here is the exact chronological anatomy of what happens inside the 90-day exclusivity window — and how $4.2M becomes $3.15M.
The Defense Gap: How Private Equity Monetizes Asymmetric Diligence in Dental M&A
Buy-side diligence teams spend $1.2-3M per transaction while sellers spend almost nothing. SRS Acquiom data shows 85% of deals face post-LOI adjustments. Here's why the clinical data layer is where dental-specific value extraction happens.
The KPIs That Kill Your Multiple: Which Dental Practice Metrics Institutional Buyers Actually Score
Not all dental KPIs matter at exit. Here are the metrics PE-backed buyers weight most, the thresholds that move multiples, and the vanity metrics they ignore entirely.
How DSOs Actually Evaluate Your Dental Practice: The 11 Underwriting Criteria They Score But Never Publish
Former NADG regional director reveals the 11 criteria DSO underwriting teams actually score — and the specific thresholds that separate premium multiples from discount ones.
The Same Playbook: What a Harvard Hospital Study Tells Us About the Future of Dental Practice Valuations
A Harvard study on PE-owned hospitals revealed a 13% rise in ER deaths after acquisition. The same debt-loading, cost-cutting playbook runs in dental M&A — and understanding it is the difference between a defended exit and a seven-figure re-trade.
The Dental Practice Data Room: What to Build, How to Structure It, and Why Starting 5 Years Early Changes Your Multiple
Most sellers assemble data rooms in 60 days. Here's the forensic-grade folder structure PE buyers actually expect — and why building it early changes your multiple.
The Algorithmic Denial Machine: How Payer AI Is Weaponizing Your Radiographs
Insurance payers are deploying pixel-level AI to deny claims at scale. The same weaponization PE firms use during QoE is coming to every claim you submit.
The Data Room Nobody Builds: What Buyers See That Sellers Never Prepare
A QoE team spends 30 days dismantling the story you spent 30 years building. Sellers who pre-audit their data room dictate the terms of their exit.
The Silent Margin Collapse: Clinical Judgment as Enterprise Value Destruction
A single D4910-to-D1110 downgrade costs $70. Repeated daily across 3 locations, it erases $504,000 in enterprise value at a 6x multiple.
The Due Diligence Ambush: How PE Weaponizes Your Data to Hijack Your Exit
Private Equity QoE teams extract raw PMS data to systematically dismantle your EBITDA. A $3M group lost $13.8M in enterprise value to unsanitized data.
Eyes Wide Open: What I Wish Every Dentist Knew Before Signing a DSO Contract
DSO contracts are built to maximize platform EBITDA, not doctor compensation. Realization rate traps, capitation true-ups, and non-competes explained.
EBITDA Laundering: The Clinical Blind Spot in Dental M&A
The EBITDA Laundering blind spot in dental M&A: how compliant-looking revenue masks clinical fraud that survives standard due diligence.
The EBITDA Illusion: Why DSOs Buy You at 5x and Trade at 14x (And How to Keep the Difference)
Why dental DSOs trade at 14x while acquirers pay 5x — understand the Multiple Arbitrage mechanism that transfers wealth from practices to PE.